Epperly Melissa B, — SEC insider filings

SEC reporting owner CIK 1807359. 56 insider filings on record with FilingPulse; latest filed 2026-10-27.

Transaction summary — filings shown

Covers the 50 most recent of 56 filings on record, filed 2021-03-03 to 2026-10-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Zentalis Pharmaceuticals, Inc. (ZNTL)Chief Financial Officer162 legs · 9,611 sh · $499,74828 legs · 73,007 sh · $2,721,9858
Roivant Sciences Ltd. (ROIV)Director25—7 legs · 82,299 sh · $2,647,91634
Kinnate Biopharma Inc. (KNTE)Director4——7
Nautilus Biotechnology, Inc. (NAUT)Director5——5

Insider filings — Epperly Melissa B,

FiledFormIssuerReported transactionsSource
2026-10-274Roivant Sciences Ltd. (ROIV)Grant/award (A): 513 @ $0 · Tax withholding (F): 116 @ $36.49EDGAR
2026-10-054Roivant Sciences Ltd. (ROIV)Option exercise (M): 17,750 @ $4.46 · Sale (S): 16,850 @ $36.08 · Sale (S): 900 @ $36.57 · Option exercise (M): 17,750 (derivative) @ $0EDGAR
2026-09-184Roivant Sciences Ltd. (ROIV)Grant/award (A): 5,054 @ $0 · Grant/award (A): 10,531 (derivative) @ $0EDGAR
2026-09-174Roivant Sciences Ltd. (ROIV)Sale (S): 4,338 @ $39.65 · Sale (S): 600 @ $40.38EDGAR
2026-09-144Roivant Sciences Ltd. (ROIV)Tax withholding (F): 2,179 @ $40.94EDGAR
2026-07-214Roivant Sciences Ltd. (ROIV)Grant/award (A): 543 @ $0EDGAR
2026-07-014Roivant Sciences Ltd. (ROIV)Option exercise (M): 17,750 @ $4.46 · Sale (S): 15,002 @ $34.32 · Sale (S): 2,748 @ $34.71 · Option exercise (M): 17,750 (derivative) @ $0EDGAR
2026-06-224Nautilus Biotechnology, Inc. (NAUT)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2026-04-214Roivant Sciences Ltd. (ROIV)Grant/award (A): 670 @ $0EDGAR
2026-03-184Roivant Sciences Ltd. (ROIV)Sale (S): 41,861 @ $28.68EDGAR
2026-01-224Roivant Sciences Ltd. (ROIV)Grant/award (A): 815 @ $0 · Tax withholding (F): 54 @ $22.98EDGAR
2025-10-224Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,056 @ $0EDGAR
2025-09-124Roivant Sciences Ltd. (ROIV)Grant/award (A): 14,524 @ $0 · Other (J): 1,661 @ $13.77 · Grant/award (A): 33,726 (derivative) @ $0EDGAR
2025-07-214Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,609 @ $0EDGAR
2025-06-254Nautilus Biotechnology, Inc. (NAUT)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2025-04-214Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,847 @ $0EDGAR
2025-01-274Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,672 @ $0 · Tax withholding (F): 180 @ $11.21EDGAR
2024-10-234Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,613 @ $0EDGAR
2024-09-164Roivant Sciences Ltd. (ROIV)Other (J): 4,245 @ $12.12EDGAR
2024-09-124Roivant Sciences Ltd. (ROIV)Grant/award (A): 16,406 @ $0 · Grant/award (A): 27,894 (derivative) @ $0EDGAR
2024-07-254Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,702 @ $0EDGAR
2024-06-174Nautilus Biotechnology, Inc. (NAUT)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2024-04-264Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,146 @ $0 · Tax withholding (F): 123 @ $10.90EDGAR
2024-04-054Kinnate Biopharma Inc. (KNTE)Disposition to issuer (D): 60,751 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 20,250 (derivative)EDGAR
2024-02-124Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 2,573 @ $11.44EDGAR
2024-02-054Zentalis Pharmaceuticals, Inc. (ZNTL)Grant/award (A): 75,000 @ $0 · Sale (S): 8,669 @ $11.54 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2024-01-234Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,207 @ $0EDGAR
2023-10-184Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,226 @ $0EDGAR
2023-10-064Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 4,594 @ $19.43 · Sale (S): 888 @ $19.91EDGAR
2023-09-144Roivant Sciences Ltd. (ROIV)Grant/award (A): 17,825 @ $0 · Grant/award (A): 26,595 (derivative) @ $0EDGAR
2023-07-064Roivant Sciences Ltd. (ROIV)Grant/award (A): 1,280 @ $0EDGAR
2023-06-164Nautilus Biotechnology, Inc. (NAUT)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2023-06-134Kinnate Biopharma Inc. (KNTE)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-02-144Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 2,624 @ $20.42 · Sale (S): 5,227 @ $19.98EDGAR
2023-02-014Zentalis Pharmaceuticals, Inc. (ZNTL)Grant/award (A): 101,957 @ $0 · Grant/award (A): 148,043 (derivative) @ $0EDGAR
2022-10-034Zentalis Pharmaceuticals, Inc. (ZNTL)Grant/award (A): 50,000 @ $0EDGAR
2022-07-254Roivant Sciences Ltd. (ROIV)Grant/award (A): 186,916 (derivative) @ $0EDGAR
2022-06-164Nautilus Biotechnology, Inc. (NAUT)Grant/award (A): 86,467 (derivative) @ $0EDGAR
2022-06-154Kinnate Biopharma Inc. (KNTE)Grant/award (A): 20,250 (derivative) @ $0EDGAR
2022-04-054Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 8,094 @ $48.75 · Sale (S): 1,303 @ $49.90 · Sale (S): 2,818 @ $50.70 · Sale (S): 4,512 @ $51.99 · Sale (S): 353 @ $52.44EDGAR
2022-02-234Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 1,211 @ $48.81 · Sale (S): 702 @ $49.59EDGAR
2022-02-144Zentalis Pharmaceuticals, Inc. (ZNTL)Grant/award (A): 16,405 @ $0 · Grant/award (A): 38,489 (derivative) @ $0EDGAR
2021-10-044Zentalis Pharmaceuticals, Inc. (ZNTL)Tax withholding (F): 17,080 @ $67.13EDGAR
2021-08-204Zentalis Pharmaceuticals, Inc. (ZNTL)Purchase (P): 1,326 @ $52.00 · Purchase (P): 8,285 @ $52.00EDGAR
2021-07-064Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 700 @ $50.10 · Sale (S): 1,378 @ $51.15 · Sale (S): 805 @ $52.01 · Sale (S): 200 @ $53.19EDGAR
2021-06-144Kinnate Biopharma Inc. (KNTE)Grant/award (A): 20,250 (derivative) @ $0EDGAR
2021-06-024Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 2,883 @ $53.99 · Sale (S): 200 @ $54.90EDGAR
2021-05-054Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 350 @ $56.99 · Sale (S): 661 @ $58.04 · Sale (S): 950 @ $59.83 · Sale (S): 1,122 @ $60.14EDGAR
2021-04-064Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 3,083 @ $43.43 · Sale (S): 13,792 @ $43.37 · Sale (S): 149 @ $44.21 · Sale (S): 83 @ $45.06EDGAR
2021-03-034Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 3,083 @ $41.67EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1807359 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs